Citicoline as Neuroprotector in Preterm

ConditionPre-Term

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

AgeUp to 1

SponsorSherief Abd-Elsalam

About this trial

Citicoline as neuroprotector in preterm

Eligibility criteria

Qualifiers

Preterm on CPAP or ventilator

Disqualifiers

Multiple congenital anomalies

Trial design

Treatments tested in this trial

Citicoline
Placebo oral tablet

Treatment groups

40 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov